The U.S. Food and Drug Administration (FDA) unveiled a new set of guidelines on August 15, 2023, concerning informed consent, building upon their 2014 draft. The release is a testament to the FDA’s dedication to refining the procedures around clinical trials. In this post, we’re spotlighting the major takeaways from these updates.

Key Themes in